Larimar Therapeutics Ownership | Who Owns Larimar Therapeutics?


OverviewForecastFinancialsChart

Larimar Therapeutics Ownership Summary


Larimar Therapeutics is owned by 96.07% institutional investors, 1.72% insiders, and 2.21% retail investors. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 33.28% of LRMR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.10% of its assets in Larimar Therapeutics shares.

LRMR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLarimar Therapeutics96.07%1.72%2.21%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deerfield management company, l.p. (series c)21.23M33.28%$82.17M
Janus henderson group6.44M10.10%$24.94M
Ra capital management6.05M9.47%$23.40M
Blue owl capital lp4.65M7.29%$18.01M
Goldman sachs group4.15M6.51%$16.07M
Blackrock3.13M5.85%$22.72M
Blackrock funding, inc. /de3.27M5.12%$12.64M
Vanguard group2.19M3.44%$8.49M
Adage capital partners gp2.10M3.29%$8.13M
Driehaus capital management1.31M2.45%$9.53M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue owl capital lp4.65M4.15%$18.01M
Deerfield management company, l.p. (series c)21.23M1.56%$82.17M
Altium capital management lp505.00K0.55%$1.95M
Dafna capital management371.43K0.37%$1.44M
Mangrove partners770.23K0.33%$2.98M
Sphera funds management455.60K0.32%$1.76M
Ra capital management6.05M0.31%$23.40M
Driehaus capital management1.31M0.09%$9.53M
Entrypoint capital54.28K0.09%$210.07K
Velan capital investment management lp18.00K0.06%$69.66K

Top Buyers

HolderShares% AssetsChange
Janus henderson group6.44M0.01%876.43K
Blackrock3.13M0.00%795.19K
Blue owl capital lp4.65M4.15%486.21K
Adage capital partners gp2.10M0.01%399.12K
Blackrock funding, inc. /de3.27M0.00%292.95K

Top Sellers

HolderShares% AssetsChange
Stempoint capital lp---704.35K
Logos global management lp---700.00K
Rtw investments, lp---650.00K
Woodline partners lp622.68K0.02%-621.87K
Millennium management254.95K0.00%-508.91K

New Positions

HolderShares% AssetsChangeValue
Balyasny asset management79.50K0.00%79.50K$307.65K
Alps advisors51.59K0.00%51.59K$199.65K
Walleye trading25.00K0.00%25.00K$96.75K
Axq capital, lp23.58K0.04%23.58K$91.25K
Aquatic capital management18.16K0.00%18.16K$70.28K

Sold Out

HolderChange
National bank of canada /fi/-2.00
Federated hermes-3.00
Nelson, van denburg & campbell wealth management group-5.00
Capital performance advisors llp-18.00
Gamma investing-44.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024116-8.66%61,296,513-4.71%960.95%61-6.15%32-5.88%
Sep 30, 202412715.45%64,329,114-1.50%1000.68%654.84%34-
Jun 30, 2024110-1.79%65,308,4722.69%1210.58%62-17.33%3454.55%
Mar 31, 202411251.35%63,594,67361.18%1441.79%75150.00%22-15.38%
Dec 31, 20237410.45%39,456,5091.83%891.15%3015.38%268.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.34M2.10%-
Vanguard Total Stock Mkt Idx Inv1.31M2.05%-
iShares Russell 2000 ETF1.12M1.75%-9.68K
Fidelity Advisor Biotechnology I524.80K0.82%-
Vanguard Institutional Extnd Mkt Idx Tr510.24K0.80%-
Janus Henderson Hrzn Biotec E2 USD455.10K0.71%44.02K
Invesco Dorsey Wright SmallCap Momt ETF422.53K0.66%-
Fidelity Small Cap Index422.46K0.66%-7.91K
iShares Russell 2000 Growth ETF398.93K0.62%-1.90K
Alger Small Cap Growth B398.96K0.62%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 16, 2024Hamilton Thomas Edward-Buy$500.00K
Feb 16, 2024Flynn James E * Director by DeputizationBuy$12.50M
Feb 16, 2024Flynn James E * Director by DeputizationBuy$12.50M
Feb 16, 2024Flynn James E * Director by DeputizationBuy$12.50M
Feb 14, 2024THOMAS FRANK E-Buy$22.00K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q2--
2024 Q15-
2023 Q41-
2023 Q3--

LRMR Ownership FAQ


Who Owns Larimar Therapeutics?

Larimar Therapeutics shareholders are primarily institutional investors at 96.07%, followed by 1.72% insiders and 2.21% retail investors. The average institutional ownership in Larimar Therapeutics's industry, Biotech Stocks , is 68.48%, which Larimar Therapeutics exceeds.

Who owns the most shares of Larimar Therapeutics?

Larimar Therapeutics’s largest shareholders are Deerfield management company, l.p. (series c) (21.23M shares, 33.28%), Janus henderson group (6.44M shares, 10.10%), and Ra capital management (6.05M shares, 9.47%). Together, they hold 52.85% of Larimar Therapeutics’s total shares outstanding.

Does Blackrock own Larimar Therapeutics?

Yes, BlackRock owns 5.85% of Larimar Therapeutics, totaling 3.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 795.19K shares, a 34.00% change.

Who is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.15% of its assets in 4.65M Larimar Therapeutics shares, valued at 18.01M$.

Who is the top mutual fund holder of Larimar Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Larimar Therapeutics shares, with 2.10% of its total shares outstanding invested in 1.34M Larimar Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools